6-K/A

AMENDMENT NO. 1 TO FORM 6-K

Company: XTL BIOPHARMACEUTICALS LTD
Filed: January 13, 2020
Period of Report: January 13, 2020
Accession Number: 0001213900-20-000834

View Document ↗ View on SEC.gov ↗